脓毒症患者C反应蛋白再升高与持续性炎症、免疫抑制和分解代谢综合征发生相关
该回顾性队列研究纳入282例符合Sepsis-3标准且ICU住院≥15天的脓毒症患者,测量前14天内C反应蛋白再升高的次数和最大幅度以代表多次打击,评估第15-28天PICS的发生。PICS组(n=145)的C反应蛋白再升高次数和最大升幅均显著大于非PICS组(n=137)(2 vs 1,P<0.001;3.3 vs 1.3 mg/dL,P<0.001)。多变量条件logistic回归显示,再升高次数和最大升幅均与PICS发生显著相关(调整OR分别为1.57(95%CI 1.12-2.21),P=0.009;1.10(95%CI 1.02-1.19),P=0.012)。作者认为,ICU入住后14天内C反应蛋白再升高与脓毒症患者15-28天内发生PICS显著相关。
要点
- 脓毒症患者ICU入住后14天内C反应蛋白再升高次数≥2次者,第15-28天PICS发生风险显著高于再升高1次者(调整OR 1.57,95%CI 1.12-2.21,P=0.009)。
- 前14天C反应蛋白最大再升幅每增加1 mg/dL,PICS发生风险调整OR为1.10(95%CI 1.02-1.19,P=0.012)。
- PICS组C反应蛋白再升高次数中位数为2次,非PICS组为1次(P<0.001);PICS组最大再升幅中位数为3.3 mg/dL,非PICS组为1.3 mg/dL(P<0.001)。
- 该研究为回顾性队列,纳入282例ICU脓毒症患者,PICS组145例,非PICS组137例,PICS评估窗口为第15-28天。
适用人群与场景
- ICU中符合Sepsis-3标准的脓毒症患者,且ICU住院时间≥15天。
诊断标准与关键阈值
- 脓毒症诊断采用Sepsis-3标准。
- PICS评估在第15-28天进行。
- C反应蛋白再升高次数和最大再升幅测量于入住ICU后前14天。
研究设计与关键结果
- 研究类型:回顾性队列研究;样本量282例ICU脓毒症患者,PICS组145例,非PICS组137例;研究未报告中心数。
- 主要终点:PICS组C反应蛋白再升高次数中位数2次 vs 非PICS组1次(P<0.001);PICS组最大再升幅中位数3.3 mg/dL vs 非PICS组1.3 mg/dL(P<0.001)。
- 多变量条件logistic回归:C反应蛋白再升高次数与PICS发生独立相关,调整OR 1.57(95%CI 1.12-2.21),P=0.009;最大再升幅与PICS发生独立相关,调整OR 1.10(95%CI 1.02-1.19),P=0.012。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,ICU入住后14天内C反应蛋白再升高与脓毒症患者15-28天内发生PICS显著相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Multiple insults, such as infection and trauma, can induce the features of persistent inflammation, immunosuppression, and catabolism syndrome (PICS) in animal models.
METHODS: We performed a retrospective cohort study to investigate the relationship between multiple insults and the development of PICS in patients with sepsis. The study was conducted on 282 intensive care unit patients with sepsis (Sepsis-3 criteria) hospitalized for ≥15 days. The number and sizes of C-reactive protein (CRP) reincreases during the first 14 days were measured to represent multiple insults. PICS development was assessed between days 15 and 28.
RESULTS: Patients in the PICS group (n = 145) had significantly larger numbers of CRP reincreases and the size of the largest CRP reincrease than the non-PICS group (n = 137) (2 vs . 1, P < 0.001; and 3.3 vs . 1.3 mg/dL, P < 0.001; respectively). Multivariable conditional logistic regression analysis showed that both the number of CRP reincreases and the size of the largest CRP reincrease were significantly associated with PICS development [adjusted odds ratio (95% confidence interval), 1.57 (1.12-2.21), P = 0.009; and 1.10 (1.02-1.19), P = 0.012; respectively].
CONCLUSIONS: These findings suggest that CRP reincreases within the 14 days following intensive care unit admission are significantly associated with the development of PICS in patients with sepsis within 15-28 days.
参考来源
- Kishimoto T, Mizumura N, Matsubayashi J, et al. Reincreases in C-Reactive Protein in Patients With Sepsis are Associated With the Development of Persistent Inflammation, Immunosuppression, and Catabolism Syndrome. Shock. 2025. PMID: 40997318. doi:10.1097/SHK.0000000000002705
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。